Chris has been Director of Ligand Binding and Exploratory Bioanalysis at inVentiv Health Clinical since 2010. Prior to this, Chris served as Scientific Director of the Ligand Binding/Cell Based Assays at MDS Pharma Services’ North American macromolecule bioanalytical operations. He has been responsible supervising the development and validation of all bioanalytical methods for the measurement of pharmaceuticals and biomarkers, immunogenicity testing and cell based neutralizing antibody assays. He previously held the position of Associate Director of Ligand Binding Services/Cell Based Assays overseeing the Montreal, Quebec operations. Before joining MDS Pharma Services in 2004 as a Team Leader in the Ligand Binding Department, Chris served as an investigator at Cogent Neuroscience, a startup biotech company in North Carolina’s RTP. Chris obtained his PhD in Neuroscience at Dalhousie University in Canada in 1995.